The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Onvansertib plus standard-of-care chemotherapy plus bevacizumab in first-line RAS-mutated metastatic colorectal cancer (mCRC): Interim results from the phase 2 randomized CRDF-004 trial.
 
Heinz-Josef Lenz
Honoraria - Abbvie; Adagene; Bayer; Boehringer Ingelheim; Fulgent Genetics; Janssen Oncology; Jazz Pharmaceuticals; Merck Serono; Merus; Roche
Consulting or Advisory Role - 3T BioSciences; Abbvie; Adagene; Bayer; BMS; Fulgent Genetics; GlaxoSmithKline; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; BMS; Merck Serono
 
Hao Xie
Consulting or Advisory Role - Cardiff Oncology (Inst); NED Biosystems, Inc. (Inst); Xilio Therapeutics (Inst)
Research Funding - AstraZeneca (Inst); BeiGene (Inst); BioNTech SE (Inst); Cardiff Oncology (Inst); DynamiCure Biotechnology (Inst); Innovent Biologics (Inst); Pfizer (Inst); Qurient Therapeutics (Inst); SparX Biopharmaceutical Corp (Inst); Xilio Therapeutics (Inst); Xilis (Inst)
 
Daniel Ahn
Stock and Other Ownership Interests - Lilly; Natera
Consulting or Advisory Role - Ipsen
Research Funding - AstraZeneca; Bayer
 
David Bajor
Employment - University Hospitals Case Medical Center
Stock and Other Ownership Interests - Erasca, Inc; Mirati Therapeutics; Revolution Medicines
Honoraria - Agenus; Tempus
Consulting or Advisory Role - Guidepoint Global
Research Funding - Abbvie; Apexigen (Inst); Arvinas (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb/Celgene (Inst); Calithera Biosciences (Inst); GlaxoSmithKline (Inst); Rafael Pharmaceuticals (Inst); Seagen (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Cardinal Health
(OPTIONAL) Uncompensated Relationships - Alligator Bioscience
 
Adel Kardosh
Consulting or Advisory Role - AstraZeneca; Cardiff Oncology; Eisai; Genentech
Speakers' Bureau - Cholangiocarcinoma Foundation
Research Funding - Natera
 
Alisha Bent
No Relationships to Disclose
 
Alex Kane
Employment - Cardiff Oncology
Stock and Other Ownership Interests - Cardiff Oncology
Research Funding - Cardiff Oncology
Travel, Accommodations, Expenses - Cardiff Oncology
 
Ramanand Subramanian
Consulting or Advisory Role - Cardiff Oncology
Travel, Accommodations, Expenses - Cardiff Oncology
 
Alex Dmitrienko
Consulting or Advisory Role - Cardiff Oncology
Travel, Accommodations, Expenses - Cardiff Oncology
 
Roger Sidhu
Employment - Cardiff Oncology
Leadership - Cardiff Oncology
Stock and Other Ownership Interests - Cardiff Oncology
Consulting or Advisory Role - Cardiff Oncology
Travel, Accommodations, Expenses - Cardiff Oncology
 
Joel Hecht
Stock and Other Ownership Interests - Actym Therapeutics; Johnson & Johnson (I); Rafael Pharmaceuticals; Trumvira
Consulting or Advisory Role - Agenus; ALX Oncology; BeiGene; Boehringer Ingelheim; Cardiff Oncology; Cartography; Civala; Curium Pharma; Fog Pharmaceuticals; Genmab; MBQ Pharma; Merus NV; Revolution Medicines; Urogen pharma; Xilio Therapeutics; Xilio Therapeutics
Research Funding - A2 Biotherapeutics (Inst); Affini-T Therapeutics (Inst); Agenus (Inst); Amgen (Inst); Bold Therapeutics (Inst); Camurus (Inst); Cardiff Oncology (Inst); CG Pharmaceuticals (Inst); Crinetics Pharmaceuticals (Inst); Exelixis (Inst); Gilead Sciences (Inst); Gritstone Bio (Inst); Janssen Oncology (Inst); Lyell Immunopharma (Inst); Merck (Inst); Mirati Therapeutics (Inst); Neogene Therapeutics (Inst); NGM Biopharmaceuticals (Inst); Regeneron (Inst); Revolution Medicines (Inst); Seagen (Inst); Tizona Therapeutics, Inc. (Inst); Tizona Therapeutics, Inc. (Inst); Xilio Therapeutics (Inst)
Travel, Accommodations, Expenses - A2 Biotherapeutics